MEIS2 and Miyoshi myopathy: Based on the antiproliferative and pro-apoptotic effects of reduced MEIS2 levels, and the BETi-mediated anticancer activities against MM33,51, we speculated that the epigenetic readers of acetylated histones, BET proteins, could regulate the expression of MEIS2 in MM.